AQR Capital Management
FURX

AQR Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

AQR Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-745,469
Closed -$79.2M – 2687
2014
Q2 		$79.2M Buy
745,469
+710,053
+2,005% +$69.6M 0.21% 127
2014
Q1 		$3.08M Buy
35,416
+22,600
+176% +$1.74M 0.01% 1079
2013
Q4 		$538K Buy
12,816
+1,500
+13% +$61.7K ﹤0.01% 2029
2013
Q3 		$498K Buy
11,316
+100
+0.9% +$4.14K ﹤0.01% 1980
2013
Q2 		$382K Buy
+11,216
New +$394K ﹤0.01% 2002

AQR Capital Management's FURX Position: Q3 2014 in Review

AQR Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 745,469 shares — an estimated $79.2M sold.

AQR Capital Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $79.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • AQR Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • AQR Capital Management sold 745,469 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $79.2M.
  • AQR Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • AQR Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $79.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on AQR Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.